Editorial: Evidence-Based Anti-Inflammatory, Anti-Hypoperfusion and Anti-Anxiety/Insomnia Therapies Show Promises for TBI-Induced Post-Traumatic Symptoms and Cognitive Deficits: Advances in Diagnosis and Treatment of TBI-Induced Neurodegeneration and Cognitive Deficits

Front Neurol. 2021 Aug 11:12:695629. doi: 10.3389/fneur.2021.695629. eCollection 2021.

Guoqiang Xing^{1

2

3}, Yu Zhang⁴, Yumin Zhang⁵, Maheen Mausoof Adamson^{3

4}, Ansgar J Furst^{3

4}, John Wesson Ashford^{3

4}

¹ Affiliated Hospital and the Second Clinical Medical College of North Sichuan Medical University, Nanchong Central Hospital, Nanchong, China.
² Lotus Biotech.com LLC, Gaithersburg, MD, United States.
³ School of Medicine, Stanford University, Stanford, CA, United States.
⁴ Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, United States.
⁵ Uniformed Services University of the Health Sciences, Bethesda, MD, United States.

No abstract available

Keywords: cognitive deficits; evidence-based therapies; innovative diagnosis; post-traumatic symptoms; traumatic brain injury.

Publication types